Inclisiran First Strategy Safe, Effective for LDL-C Control in ASCVD Patients
New data from a phase 3b trial presented at ACC.24 underlines the potential of inclisiran in reducing LDL-C levels among patients with ASCVD.
Stay updated with breaking news from Usual Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New data from a phase 3b trial presented at ACC.24 underlines the potential of inclisiran in reducing LDL-C levels among patients with ASCVD.
Early metformin initiation as an adjunct to usual care does not significantly improve maternal gestational diabetes outcomes.
A clinical trial conducted by UNM has identified the best care practices for newborns exposed to opioids. According to recent research by the University of New Mexico, hugging and swaddling newborns exposed to opioids can decrease their hospitalization period by nearly a week, in contrast to tradit
Relaxation can benefit your mental and physical health. Learn more about how it affects your body and the best ways to unwind.
/PRNewswire/ -- A targeted survey released by patient advocacy group, United Stroke Alliance, with support from Medtronic, found that while nearly 80% of...